Trimi vs Hers: Compounded Semaglutide vs FDA-Approved Wegovy
Trimi vs Hers is a comparison between a compounded-medication model and a brand-name, FDA-approved option. Early verdict: choose Trimi if you want compounded semaglutide with flat, dose-independent pricing and free overnight shipping; choose Hers if you prefer FDA-approved Wegovy and a personalized care team with ongoing dose check-ins.
Explore Trimi plans from $99/mo
How they differ at a glance
This comparison focuses on the most distinctive differences: medication type and regulatory status, pricing and membership structure, shipping and refunds, provider oversight and availability, and approach to name-brand versus compounded options. All claims below are taken from each provider’s stated materials.
Medication type and regulatory status
Trimi prescribes compounded semaglutide and tirzepatide prepared by state-licensed 503A pharmacies. The source states that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Hers offers FDA-approved Wegovy, a brand-name semaglutide, and explicitly notes it is not a compounded product.
Pricing, membership and what is included
Trimi lists compounded semaglutide from $99/month on the annual plan and tirzepatide at $125/month, with flat pricing that does not rise as dose increases. Trimi also highlights a 6-month money-back promise with terms. Hers lists Wegovy from $149/month and notes membership is required; an active Hers Weight Loss Membership is required and membership and medication are billed separately, with membership auto-renewing at $149/month after the first month.
See Trimi pricing and refund policy
Shipping, delivery and refunds
Trimi advertises free overnight, temperature-controlled shipping and states a 100% automatic refund if not approved by the medical team plus a 6-month money-back promise for weight-loss outcomes under stated terms. Hers describes medication pricing and membership requirements but does not advertise a comparable shipping promise in the captured evidence.
Provider oversight and program model
Trimi’s clinical oversight is provided by licensed U.S. providers through Arora Health, led by Medical Director Dr. Sean Arora, MD, and names compounding pharmacies. Hers promotes a personalized care team with ongoing dose check-ins and emphasizes FDA-approved, brand-name GLP-1 options.
State availability and prescription notes
Trimi indicates licensed providers and named compounding pharmacies and mentions prescription and state coverage considerations. Hers notes that some medications are not available in all 50 states and that treatment is available only when a licensed clinician determines it is medically appropriate. Both sources advise confirming eligibility, medication, total cost, renewal terms and state availability before enrollment.
| Criteria | Trimi | Hers |
|---|---|---|
| Medication type | Compounded semaglutide and tirzepatide | FDA-approved Wegovy and other brand-name GLP-1s |
| Starting price | Semaglutide from $99/mo on annual plan | Wegovy from $149/mo; injectable from $199/mo |
| Membership required | Not described as required; flat membership covers medication and visits on some plans | Active Hers Weight Loss Membership required; billed separately |
| Shipping | Free overnight, temperature-controlled shipping | Shipping not specified in captured evidence |
| Refunds / guarantees | 6-month money-back promise; 100% automatic refund if not approved by medical team | No comparable refund promise captured |
| Regulatory note | Compounded medications are not FDA-approved | Offers FDA-approved brand-name medications; notes some uses may be off-label |
Choosing based on what matters to you
If price and flat, dose-independent monthly cost are your priorities, Trimi documents compounded semaglutide from $99/month on annual plans and free overnight shipping, plus a stated 6-month money-back promise. If you prefer an FDA-approved brand-name semaglutide with a named personalized care team and ongoing dose check-ins, Hers presents Wegovy from $149/month with membership requirements.
View Hers Wegovy options from $149/mo
Final comparison and recommendation
Trimi vs Hers comes down to compounded versus FDA-approved medication, starting price and membership structure, and shipping and refund policies. Trimi emphasizes compounded medication, flat pricing, free overnight shipping and a 6-month money-back promise. Hers emphasizes FDA-approved Wegovy, a personalized care team, and a required membership with separate billing for medication.
Choose Trimi if you prioritize compounded semaglutide from $99/mo, flat pricing that does not change with dose, free overnight shipping, and a stated 6-month money-back promise. Choose Hers if you need an FDA-approved, brand-name option like Wegovy with a personalized care team and ongoing dose check-ins. Verify eligibility, state availability, total cost and renewal terms with each provider before enrolling, and note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.